111 related articles for article (PubMed ID: 1970345)
1. High-performance liquid chromatographic assay for nizatidine, a new H2 blocker, in human plasma and urine using disposable solid-phase extraction columns.
Carlucci G
J Chromatogr; 1990 Feb; 525(2):490-4. PubMed ID: 1970345
[No Abstract] [Full Text] [Related]
2. Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine.
Vincek WC; Constanzer ML; Hessey GA; Bayne WF
J Chromatogr; 1985 Mar; 338(2):438-43. PubMed ID: 2860117
[No Abstract] [Full Text] [Related]
3. Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography.
Tracqui A; Kintz P; Mangin P
J Chromatogr; 1990 Aug; 529(2):369-76. PubMed ID: 1977754
[TBL] [Abstract][Full Text] [Related]
4. Nizatidine, an H2-blocker. Its metabolism and disposition in man.
Knadler MP; Bergstrom RF; Callaghan JT; Rubin A
Drug Metab Dispos; 1986; 14(2):175-82. PubMed ID: 2870891
[TBL] [Abstract][Full Text] [Related]
5. Extraction of ranitidine and nizatidine with using imidazolium ionic liquids prior spectrophotometric and chromatographic detection.
Kiszkiel I; Starczewska B; Leśniewska B; Późniak P
J Pharm Biomed Anal; 2015 Mar; 106():85-91. PubMed ID: 25498149
[TBL] [Abstract][Full Text] [Related]
6. Validation of a new high-performance liquid chromatography assay for nizatidine.
Yusuf A; Al Dgither S; Hammami MM
Ther Drug Monit; 2006 Apr; 28(2):232-6. PubMed ID: 16628136
[TBL] [Abstract][Full Text] [Related]
7. [Liquid chromatography in pharmaceutical analysis: determination in tablets of famotidine, a new H2-antagonists].
Ficarra R; Ficarra P; Calabrò ML
Farmaco Prat; 1987 Nov; 42(11):307-12. PubMed ID: 2893743
[No Abstract] [Full Text] [Related]
8. HPLC fluorescence method for the determination of nizatidine in human plasma and its application to pharmacokinetic study.
Çakar MB; Ulu ST
Luminescence; 2014 Jun; 29(4):357-61. PubMed ID: 23836529
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a sensitive LC-MS/MS assay for the quantification of nizatidine in human plasma and urine and its application to pharmacokinetic study.
Shang DW; Wang ZZ; Ni XJ; Zhang M; Hu JQ; Qiu C; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():80-7. PubMed ID: 26197435
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic determination of a new calcium antagonist, fostedil, in plasma and urine using fluorescence detection.
Thomas EW
J Chromatogr; 1984 Jan; 305(1):233-8. PubMed ID: 6538578
[No Abstract] [Full Text] [Related]
11. Study of plasma, urine and gastric juice concentrations of famotidine using high performance liquid chromatography.
Bologna M; Biordi L; Napolitano T; Carlucci G
Int J Clin Pharmacol Res; 1988; 8(5):335-40. PubMed ID: 3229873
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic determination of famotidine in urine.
Rahman A; Hoffman NE
J Chromatogr; 1988 Jul; 428(2):395-401. PubMed ID: 2905703
[No Abstract] [Full Text] [Related]
13. Development of a Validated Comparative Stability-Indicating Assay Method for Some H2-Receptor Antagonists.
Ahmed S; Elshaboury SR; Mohamed NA; Farrag S
J Chromatogr Sci; 2017 Sep; 55(8):818-831. PubMed ID: 28486578
[TBL] [Abstract][Full Text] [Related]
14. Validated and optimized high-performance liquid chromatographic determination of tizoxanide, the main active metabolite of nitazoxanide in human urine, plasma and breast milk.
Hadad GM; Abdel Salam RA; Emara S
J Chromatogr Sci; 2012 Jul; 50(6):509-15. PubMed ID: 22525879
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a new H2 receptor antagonist, 3-amino-5-[3-[4-(1-piperidinoindanyloxy)]propylamino]-1-methyl-1 H-1,2,4-triazole, in human plasma and urine by high-performance liquid chromatography.
Miksic JR; Rivel ER; Rush K
J Chromatogr; 1988 Jun; 428(1):113-21. PubMed ID: 2902101
[TBL] [Abstract][Full Text] [Related]
16. [High pressure liquid-liquid chromatography. Quantitative determination of histamine H2 antagonists].
Gaetani E; Laureri CF; Ronchini F
Farmaco Prat; 1978 Nov; 33(11):484-8. PubMed ID: 35364
[No Abstract] [Full Text] [Related]
17. Determination of a new antiulcer agent, YJA-20379-1 in plasma, urine, blood, and tissue homogenates by high-performance liquid chromatography.
Kim SH; Choi WS; Chang MS; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):107-12. PubMed ID: 9507573
[TBL] [Abstract][Full Text] [Related]
18. Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.
Ashiru DA; Patel R; Basit AW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):235-40. PubMed ID: 18006395
[TBL] [Abstract][Full Text] [Related]
19. High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.
Randolph WC; Osborne VL; Walkenstein SS; Intoccia AP
J Pharm Sci; 1977 Aug; 66(8):1148-50. PubMed ID: 19614
[TBL] [Abstract][Full Text] [Related]
20. Absorption studies of the H2-blocker nizatidine.
Knadler MP; Bergstrom RF; Callaghan JT; Obermeyer BD; Rubin A
Clin Pharmacol Ther; 1987 Nov; 42(5):514-20. PubMed ID: 2890459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
